- ANGLE has established a collaboration with Philips to develop liquid biopsy solutions.

Philips has successfully secured a European Union research grant worth €6.3 million, of which £0.4 million will flow to ANGLE.

Philips has selected ANGLE's Parsortix system as the sole system to be used for harvesting circulating tumour cells (CTCs) for analysis in the research collaboration, which is an important area of development for Philips following its restructuring in 2016 to focus on healthcare.

The collaboration is planned for a four year period. It is estimated that grant funding of £0.1 million and £0.2 million will be received by ANGLE in the financial years ending 30 April 2018 and 2019, respectively. The remaining £0.1 million will spread over the following three financial years.

At 8:11am: [LON:AGL] Angle PLC share price was +2p at 42p

Story provided by